Skip to main content
. 2021 Feb 18;13(4):860. doi: 10.3390/cancers13040860

Table 3.

Univariate and multivariate analysis of progression-free survival.

Characteristics Univariate Analysis Multivariate Analysis
HR (95%CI) p-Value HR (95%CI) p-Value
Age, years (≥65) 1.41 (0.66–2.99) 0.373 -
Gender (female) 0.91 (0.34–2.39) 0.842 -
Smoking history
(current or former)
1.20 (0.57–2.54) 0.625 -
Histopathology
(clear cells)
2.22 (0.88–5.58) 0.089 2.09 (0.72–6.02) 0.173
Skin toxicity
(present)
0.33 (0.11–0.95) 0.041 0.36 (0.12–1.06) 0.065
Thyroid disfunction (present) 0.36 (0.15–0.89) 0.028 0.34 (0.13–0.87) 0.025
Number of irAEs (≥2) 0.33 (0.13–0.81) 0.016 0.32 (0.13–0.79) 0.014

HR = hazard ratio; CI = confidence interval; irAEs = immune-related adverse events.